Searchable abstracts of presentations at key conferences in endocrinology

ea0056p1144 | Thyroid cancer | ECE2018

Changing treatment trends with radioiodine in thyroid carcinoma at the beginning of 21st century in Castilla-La Mancha (Spain)

Delgado Manuel , Sastre Julia , Quiroga Ivan , Gonzalez Javier , Torres Belvis , Aznar Silvia , Alvarez Visitacion , Herranz Sandra , Moreno Jesus , Gomez Paz

Background and objective: The incidence of differentiated thyroid carcinoma (DTC) is increasing worldwide. Radioiodine (RAI) ablation is one of the main elements in the therapy of DTC after surgical removal of the gland. This study aims to compare the use of I131 in a Spanish Cohort of DTC before and after the American Thyroid Association (ATA) 2009 guidelines.Patients and methods: The Cadit-CAM study was designed to evaluate retrospectively characterist...

ea0063p372 | Thyroid 1 | ECE2019

Prognostic factors for lymph node metastases in patients with papillary thyroid microcarcinoma

Sastre Julia , Cruz Gordillo Andrea , Aznar Silvia , Alvarez Visitacion , Torres Belvis , Delgado Manuel , Gonzalez Javier , Quiroga Ivan , Herranz Sandra , Aguirre Miguel

Background and objective: Papillary thyroid microcarcinoma (PTMC) is recognized as a separate entity by the World Health Organization. Biological behaviour and clinical outcomes of PTMC are heterogenous. Presence of lymph node metastases (LNM) in this group of patients increases the risk of recurrence and makes optimal management in PTMC controversial (observation, lobectomy with or without preventive central ipsilateral dissection). The aim of this study was to describe risk ...

ea0056gp231 | Thyroid Cancer - Diagnostics & Treatments | ECE2018

Related recurrence factors in a Spanish cohort of differentiated thyroid carcinoma. Cadit-CAM Study

Quiroga Ivan , Sastre Julia , Delgado Manuel , Aznar Silvia , Alvarez Visitacion , Torres Belvis , Gonzalez Javier , Lamas Cristina , Llaro Mary Gaby , del Val Florentino , Calderon Dulce , Lop Jose

Background and objective: Incidence of differentiated thyroid cancer (DTC) is increasing but not its mortality. Knowing recurrence factors is essential to plan its treatment. Recurrence related factors in our area were reviewed and compared with ATA risk stratification system.Patients and Methods: The Cadit-CAM study was designed to evaluate characteristics of patients diagnosed of DTC in Castilla La Mancha, a region in the central part of Spain, during ...

ea0056gp237 | Thyroid Cancer - Translational | ECE2018

Comparison in survival of the seventh and eighth editions of the American Joint Commision on Cancer in a Spanish cohort of differentiated thyroid carcinoma: Cadit-CAM Study

Sastre Julia , Torres Belvis , Aznar Silvia , Alvarez Visitacion , Delgado Manuel , Gonzalez Javier , Quiroga Ivan , Herranz Sandra , Alfaro Jose Joaquin , Aguirre Miguel

Background and objective: The AJCC-TNM system is optimized to predict survival in patients with cancer. Since January 2018, the new eighth edition of this staging system will be used to classify patients diagnosed of differentiated thyroid carcinoma (DTC). This study aims to compare the seventh and eighth editions of the AJCC-TNM system in a Spanish Cohort of DTC.Patients and Methods: The Cadit-CAM study was designed to evaluate characteristics of patien...

ea0063gp209 | Diabetes: Pharmacotherapy | ECE2019

Efficacy and tolerability of dulaglutide in patients with type 2 diabetes: Experience on a secondary Hospital

Lazaro Paloma Gonzalez , Pascual Cristina Contreras , del Val Zaballos Florentino , Fernandez Julia Silva , Alfonso Francisco Javier Gomez , Arroyo Belvis Torres , de Agredos Alvaro Garcia Manzanares Vazquez , Garcia Ines Gomez

Introduction: Dulaglutide (Trulicity®) is a long-acting GLP-1 agonist that received US Food and Drug Administration (FDA) approval in 2014. Dulaglutide is a large sized molecule, which limits its renal clearance. This allows for once weekly dosing; which might improve patient compliance significantly. Extensive Phase III study data have been published with regard to dulaglutide, much of which was part of the AWARD studies, which provide evidence for its use in ...

ea0063ep122 | Reproductive Endocrinology | ECE2019

Severe pulmonary tromboembolism and klinefelter syndrome

Fernandez Julia Silva , Zalvide Alberto Escalera , Alfonso Francisco Javier Gomez , Zaballos Florentino Del Val , Arroyo Belvis Torres , Lazaro Paloma Gonzalez , Pascual Cristina Contreras , Mendez Cristina Montalban , Manzanares Alvaro Garcia , Garcia Ines Gomez

Introduction: Klinefelter syndrome (KS) is the most common congenital abnormality causing primary hypogonadism. KS has a tendency for hypercoagulability.Case report: A 48 year old man diagnosed as having KS during the sterility test was admitted to our hospital emergency department after suffering a syncopal episode at work. He complained of difficulty breathing during the last two weeks and he was receiving bronchodilator therapy. He had suffered deep v...